A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis.
- Authors
- Dickinson, Dwight; Ragland, J Daniel; Calkins, Monica E; Gold, James M; Gur, Ruben C
- Year
- 2006
- Journal
- Schizophrenia research
- PMID
- 16616831
- DOI
- 10.1016/j.schres.2006.03.003
- PMCID
- PMC4332573
There is evidence that cognitive task performance breaks down into the same broad domains in schizophrenia as in healthy populations. However, this does not mean that the domains are independent of one another or that the interrelationships among domains are the same between groups. We used confirmatory factor analysis (CFA) to compare the latent structure of a broad neuropsychological battery in schizophrenia patients (n = 148) and healthy controls (n = 157). Main analyses examined the fit of a hierarchical six-factor model, in which associations among the factors were assumed to reflect their strong shared relationship to a general cognitive ability factor. The model incorporated the factors of verbal comprehension, perceptual organization, verbal memory, spatial memory, processing speed, and executive/working memory. The hierarchical model provided a good overall fit to data from both groups. However multiple groups CFA revealed significant differences in factor loadings between groups, reflecting a more generalized latent structure of cognitive ability in schizophrenia. This was also evident in higher bivariate correlations among cognitive domain composite scores calculated from the observed test data. Cognitive ability, as reflected in test performance, appears to be more unitary in schizophrenia than in healthy subjects. This finding may have measurement and treatment implications.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Measurement invariance of DSM-IV alcohol, marijuana and cocaine dependence between community-sampled and clinically overselected studies. | 2013 | 23651171 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Neighborhood environmental deprivation predicts the generalized neurocognitive deficit in schizophrenia. | Zhang L et al. | β | 2026 | β |
| Genetic risk for schizophrenia and brain activation during the Penn Conditional Exclusion Test: A multiplex extended pedigree study. | Rupert PE et al. | β | 2025 | β |
| Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia. | KnΓΕΎkovΓ‘ K et al. | β | 2024 | β |
| Prosody and schizophrenia. Objective acoustic measurements of monotonous and flat intonation in young Danish people with a schizophrenia diagnosis. AΒ pilot study. | JΓΈrgensen LM et al. | β | 2024 | β |
| Psychosis superspectrum I: Nosology, etiology, and lifespan development. | Jonas KG et al. | β | 2024 | β |
| European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia. | Vita A et al. | β | 2022 | β |
| Lifespan evolution of neurocognitive impairment in schizophrenia - A narrative review. | Fett AJ et al. | β | 2022 | β |
| The network structure of cognitive deficits in first episode psychosis patients. | SΓ‘nchez-Torres AM et al. | β | 2022 | β |
| A Network of Psychopathological, Cognitive, and Motor Symptoms in Schizophrenia Spectrum Disorders. | Moura BM et al. | β | 2021 | β |
| Bifactor model of cognition in schizophrenia: Evidence for general and specific abilities. | Becker ML et al. | β | 2021 | β |
| Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders. | Eskridge CLM et al. | β | 2021 | β |
| Color Trails Test: A New Set of Data on Cognitive Flexibility and Processing Speed in Schizophrenia. | Tyburski E et al. | β | 2020 | β |
| Correlation between Performance-Based and Interview-Based Cognitive Measurements in Patients with Schizophrenia. | Jeon DW et al. | β | 2020 | β |
| Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients. | Gjerde PB et al. | β | 2020 | β |
| Cognitive Profiles and Functional Connectivity in First-Episode Schizophrenia Spectrum Disorders - Linking Behavioral and Neuronal Data. | Rodriguez M et al. | β | 2019 | β |
| Component mechanisms of executive function in schizophrenia and their contribution to functional outcomes. | Berberian AA et al. | β | 2019 | β |
| Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia. | Biagianti B et al. | β | 2019 | β |
| A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS). | Hurford IM et al. | β | 2018 | β |
| Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. | Blakey R et al. | β | 2018 | β |
| Cognitive function in early psychosis patients from a lower middle-income country. | Husain MO et al. | β | 2018 | β |
| Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis. | Grossman M et al. | β | 2017 | β |
| The course of cognitive functioning after first-episode of psychosis: A six month follow-up study. | Haring L et al. | β | 2017 | β |
| Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. | Hochberger WC et al. | β | 2016 | β |
| California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). | Stone WS et al. | β | 2015 | β |
| Cognitive structure from childhood to adulthood in kindreds densely affected by schizophrenia and bipolar disorder. | Cellard C et al. | β | 2015 | β |
| Executive function processes mediate the impact of working memory impairment on intelligence in schizophrenia. | Wongupparaj P et al. | β | 2015 | β |
| Factorial validity, measurement equivalence and cognitive performance of the Cambridge Neuropsychological Test Automated Battery (CANTAB) between patients with first-episode psychosis and healthy volunteers. | Haring L et al. | β | 2015 | β |
| Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). | McCleery A et al. | β | 2015 | β |
| Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. | Keefe RS et al. | β | 2015 | β |
| Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies. | Linssen AM et al. | β | 2014 | β |
| Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals. | Dickinson D et al. | β | 2014 | β |
| Genetic and Environmental Influences of General Cognitive Ability: Is <i>g</i> a valid latent construct? | Panizzon MS et al. | β | 2014 | β |
| Refining the latent structure of neuropsychological performance in schizophrenia. | Lam M et al. | β | 2014 | β |
| The relationship between executive functions and fluid intelligence in schizophrenia. | Roca M et al. | β | 2014 | β |
| Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool. | Fervaha G et al. | β | 2014 | β |
| Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls. | Schretlen DJ et al. | β | 2013 | β |
| Measurement invariance of DSM-IV alcohol, marijuana and cocaine dependence between community-sampled and clinically overselected studies. | Derringer J et al. | β | 2013 | β |
| Polymorphisms in schizophrenia candidate gene UFD1L may contribute to cognitive deficits. | Ota VK et al. | β | 2013 | β |
| Simulating real world functioning in schizophrenia using a naturalistic city environment and single-trial, goal-directed navigation. | Zawadzki JA et al. | β | 2013 | β |
| An integrative architecture for general intelligence and executive function revealed by lesion mapping. | Barbey AK et al. | β | 2012 | β |
| Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia. | Knowles EE et al. | β | 2012 | β |
| Hierarchical structure of the cognitive processes in schizophrenia: the fundamental role of processing speed. | Ojeda N et al. | β | 2012 | β |
| Instrument of Professional Attitude for Student Nurses (IPASN): a confirmatory factor analytic study. | Γelik B et al. | β | 2012 | β |
| Magnitude of impact of executive functioning and IQ on episodic memory in Schizophrenia. | Kopald BE et al. | β | 2012 | β |
| Understanding the executive functioning heterogeneity in schizophrenia. | Raffard S et al. | β | 2012 | β |
| A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians. | Hurford IM et al. | β | 2011 | β |
| A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. | Couture SM et al. | β | 2011 | β |
| Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. | Dickinson D et al. | β | 2011 | β |
| Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. | Lewandowski KE et al. | β | 2011 | β |
| Neurocognitive prediction of illness knowledge after psychoeducation in schizophrenia: results from the Munich COGPIP study. | Jahn T et al. | β | 2011 | β |
| Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls. | Segarra N et al. | β | 2011 | β |
| What is it like to be a person with schizophrenia in the social world? A first-person perspective study on Schizophrenic dissociality--part 1: state of the art. | Stanghellini G et al. | β | 2011 | β |
| Effect of second-generation antipsychotics on cognition: current issues and future challenges. | Hill SK et al. | β | 2010 | β |
| Factor structure of the neurocognitive tests: an application of the confirmative factor analysis in stabilized schizophrenia patients. | Noh J et al. | β | 2010 | β |
| Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis. | BΓ©chard-Evans L et al. | β | 2010 | β |
| Neurocognition in schizophrenia. | Kalkstein S et al. | β | 2010 | β |
| Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. | Kantrowitz JT et al. | β | 2010 | β |
| Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis. | Stefanopoulou E et al. | β | 2009 | β |
| Dissociation of long-term verbal memory and fronto-executive impairment in first-episode psychosis. | Leeson VC et al. | β | 2009 | β |
| Explicit identification and implicit recognition of facial emotions: II. Core domains and relationships with general cognition. | Mathersul D et al. | β | 2009 | β |
| Phenotyping psychosis: room for neurocomputational and content-dependent cognitive endophenotypes? | Chen EY et al. | β | 2009 | β |
| Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. | Lipkovich IA et al. | β | 2009 | β |
| Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. | Dickinson D et al. | β | 2009 | β |
| The genetics of schizophrenia. | Bertolino A et al. | β | 2009 | β |
| Digit symbol coding and general cognitive ability in schizophrenia: worth another look? | Dickinson D | β | 2008 | β |
| Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia. | Hill SK et al. | β | 2008 | β |
| General and specific cognitive deficits in schizophrenia: Goliath defeats David? | Dickinson D et al. | β | 2008 | β |
| Implementation considerations for multisite clinical trials with cognitive neuroscience tasks. | Keefe RS et al. | β | 2008 | β |
| Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. | Dickinson D et al. | β | 2008 | β |
| Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. | Bowie CR et al. | β | 2008 | β |
| Cognitive heterogeneity in schizophrenia. | Joyce EM et al. | β | 2007 | β |
| Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. | Genderson MR et al. | β | 2007 | β |
| Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. | Javitt DC | β | 2007 | β |
| The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. | Gur RE et al. | β | 2007 | β |
| Baseline neurocognitive deficits in the CATIE schizophrenia trial. | Keefe RS et al. | β | 2006 | β |